AI Medicine Could be First to Treat Disease With No Cure in

An AI-designed medicine for Inflammatory Bowel Disease enters Phase 1 clinical trials. Artificial Intelligence Biotech Company, Insilico Medicine, has reportedly entered the first phase of its clinical trials for the ISM5411.

Related Keywords

Pessac , Aquitaine , France , China , United States , Australia , Alex Zhavoronkov , Aldohn Domingo , Dana Farber Cancer Institute Under Scrutiny , Allegations Of Research Misconduct , Bloomberg , Artificial Intelligence Biotech Company , Tech Times , Intelligence Biotech Company , Insilico Medicine , Inflammatory Bowel Disease , Getty Images , Treefrog Therapeutics , Powered Device , Detect All , Research Misconduct Unearthed , Ai , Artificial Intelligence , Ki Medicine , Nai Drug , I Chemistry42 , Ai Technology , I Pharmaceutics , I Designed Drug , I Development , Pharmaceuticals , Harmaceutical , Biotech , Biotechnology , Inflammatory Bowel Diseases , Bd ,